Deal Type

Singapore-based private equity firm Everstone Capital has partnered with the founding promoters of India-based Apothecon and US-based Navinta, investing close to US$270m for a...

Charterhouse Capital Partners has reached an agreement to acquire all shares of York-based AIM-listed international veterinary sales and marketing organisation, Animalcare, for approximately £235.2m on...

The British Business Bank, the UK government’s economic development bank, has agreed to make a £100m (US$135.5m) commitment to Apposite Healthcare Growth I, a...

Hong Kong-listed Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialisation of innovative therapeutics, has announced that its wholly-owned...

Adcendo, a Denmark-based biotech company focused on the development of first-and best-in-class antibody-drug conjugates (ADCs) for the treatment of cancers with high unmet medical...

Nord Holding is investing in the VisionmaxX Group, the leading managed service provider (MSP) for IT services in German Austrian medical practices with a...

Swiss dental platform, DentaCore Group, has secured a financing solution of CHF150m (US$190m) to repay its existing debt and fund future acquisitions through a hunting...

Nasdaq-listed biopharmaceutical company, Gilead Sciences, is acquiring Germany-based Tubulis, for a total deal value of up to US$5bn. Under the terms of the agreement, Gilead...

Jeito Capital, an independent private equity fund dedicated to biopharma, has announced the final close of its second fund Jeito II, exceeding its €1bn...

European specialist growth buyout investment firm, Verdane, has invested in and partnered with Medadom, a French teleconsultation provider, alongside the French sovereign fund, Bpifrance. Founded...